Recruiting HIV AIDS Studies in Orlando
A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
Researchers are looking for new medicines to prevent HIV-1 (Human Immunodeficiency Virus Type 1) infection. The goals of this study are to learn: * If taking MK-8527 once a month works to prevent HI...
A Clinical Trial of STP0404 in Adults With HIV-1 Infection
The purpose of this study is to evaluate the antiviral effect, safety, tolerability, and pharmacokinetics of STP0404 in adult participants living with Human Immunodeficiency Virus Type 1 (HIV-1) infec...
About HIV AIDS Clinical Trials in Orlando
HIV (human immunodeficiency virus) attacks the immune system and, if untreated, can lead to AIDS (acquired immunodeficiency syndrome). Antiretroviral therapy (ART) can control the virus and prevent transmission. Research continues to pursue a functional cure, long-acting therapies, and preventive vaccines.
There are currently 2 hiv aids clinical trials recruiting participants in Orlando, FLORIDA. These studies are seeking a combined 4,426 participants. Research is being sponsored by Merck Sharp & Dohme LLC, ST Pharm Co., Ltd.. Clinical trial participation is free and participants receive study-related medical care at no cost.
HIV AIDS Clinical Trials in Orlando — FAQ
Are there hiv aids clinical trials in Orlando?
Yes, there are 2 hiv aids clinical trials currently recruiting in Orlando, FLORIDA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Orlando?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Orlando research site will contact you about next steps.
Are clinical trials in Orlando free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Orlando studies also compensate for your time and travel.
What hiv aids treatments are being tested?
The 2 active trials in Orlando are testing new therapies including novel drugs, biologics, and treatment approaches for hiv aids.
Data updated March 2, 2026 from ClinicalTrials.gov